verapamil and seryl-leucyl-isoleucyl-glycyl--arginyl-leucinamide

verapamil has been researched along with seryl-leucyl-isoleucyl-glycyl--arginyl-leucinamide in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kawabata, A; Kawai, K; Kawao, N; Kuroda, R; Masuko, T; Nagata, N; Nishikawa, H	1
Dou, W; Hu, J; Shen, H; Sun, J	1

Other Studies

2 other study(ies) available for verapamil and seryl-leucyl-isoleucyl-glycyl--arginyl-leucinamide

Article	Year
In vivo evidence that protease-activated receptors 1 and 2 modulate gastrointestinal transit in the mouse. British journal of pharmacology, 2001, Volume: 133, Issue:8 Topics: Amino Acid Sequence; Animals; Anti-Bacterial Agents; Apamin; Calcium Channel Blockers; Calcium Channels, L-Type; Dose-Response Relationship, Drug; Drug Synergism; Gastrointestinal Motility; Genistein; Intestinal Mucosa; Intestines; Mice; Oligopeptides; Peptides; Potassium Channel Blockers; Potassium Channels; Protein-Tyrosine Kinases; Receptor, PAR-1; Receptor, PAR-2; Receptors, Thrombin; Verapamil	2001
A comparison of the effects of nifedipine, verapamil, and low-molecular-weight heparin on SLIGRL-NH₂-induced calcium influx through proteinase-activated receptor 2 activation. Pharmacology, 2014, Volume: 93, Issue:5-6 Topics: Calcium; Calcium Channel Blockers; HEK293 Cells; Heparin, Low-Molecular-Weight; Humans; Nifedipine; Oligopeptides; Receptor, PAR-2; Verapamil	2014

Article

Year

In vivo evidence that protease-activated receptors 1 and 2 modulate gastrointestinal transit in the mouse.

British journal of pharmacology, 2001, Volume: 133, Issue:8

Topics: Amino Acid Sequence; Animals; Anti-Bacterial Agents; Apamin; Calcium Channel Blockers; Calcium Channels, L-Type; Dose-Response Relationship, Drug; Drug Synergism; Gastrointestinal Motility; Genistein; Intestinal Mucosa; Intestines; Mice; Oligopeptides; Peptides; Potassium Channel Blockers; Potassium Channels; Protein-Tyrosine Kinases; Receptor, PAR-1; Receptor, PAR-2; Receptors, Thrombin; Verapamil

2001

A comparison of the effects of nifedipine, verapamil, and low-molecular-weight heparin on SLIGRL-NH₂-induced calcium influx through proteinase-activated receptor 2 activation.

Pharmacology, 2014, Volume: 93, Issue:5-6

Topics: Calcium; Calcium Channel Blockers; HEK293 Cells; Heparin, Low-Molecular-Weight; Humans; Nifedipine; Oligopeptides; Receptor, PAR-2; Verapamil

2014